Growing Interest of Venture Capital Firms Is Boon for Gene Therapy Market
According to a new research report by RNCOS entitled, "Global Gene Therapy Market Outlook 2018", with the rise in demand of gene therapies as an alternative treatment to genetic and chronic diseases number of venture capital firms are coming forward to help biotech companies in raising funds for new gene therapies. Venture Capital Firms have been progressively investing into gene therapy space by providing ample funding support to biotech Startups. For instance, Philadelphia based gene therapy company Spark Therapeutics raised...
View full press release